Moneycontrol PRO
HomeNewsTrendsHealthAmid Delhi's COVID spike, PM Modi calls meet to review nationwide situation on April 27

Amid Delhi's COVID spike, PM Modi calls meet to review nationwide situation on April 27

India's daily coronavirus count has been climbing over the past few days, primarily due to the surge in infections in the national capital.

April 24, 2022 / 20:35 IST
Illustration of PM Narendra Modi (Image: Moneycontrol)

Prime Minister Narendra Modi will chair a meeting of top officials on April 27 to review the country's COVID-19 situation, reports said on April 24.

The meeting will be convened at "12 pm on Wednesday" via video-conferencing, news agency ANI learnt from official sources. It was not specified whether chief ministers of all states and union territories would be asked to attend.

The report comes amid an alarming surge in the coronavirus count in Delhi. The national capital accounted for 1,094 out of the 2,527 fresh cases reported over the past 24 hours, as per the last update issued by the Union health ministry.

The city's daily infection count, which had dropped below 100 last month, has been increasing constantly the first week of April. The surge in cases compelled Delhi's Aam Aadmi Party (AAP) government to reinforce the mandatory mask mandate.

At 3,975, Delhi, at present, has the highest active COVID-19 case load in the country.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The R-value, which is a key metric to assess the transmissibility of the disease, has surged to 2.1 in the city, researchers at IIT Madras said. The countrywide R-value for the week ending April 18 stood at 1.3.

Experts believe that the fresh COVID-19 surge in Delhi is being driven by Omicron sub-lineage BA.2.12. The variant has been detected in a majority of samples sent for genome sequencing from the city, sources told News18 earlier this week.

Moneycontrol learnt from top sources at Indian SARS-CoV-2 Genomics Consortium (INSACOG) that another Omicron variant derivative - BA.2.12.1 - has also been detected in a few samples sent from Delhi. However, an official confirmation was awaited.

India has so far been hit by three major waves of the COVID-19 pandemic, with the first two being the most lethal. The second wave accounted for the majority of the estimated five lakh coronavirus-related deaths recorded across the nation.

The third wave, which was triggered by the Omicron variant, had hit parts of the nation in December last year and lasted till February. The fatality-count, however, remained low, which experts attributed to the immunity gained by the bulk of the population through vaccination and exposure to the virus.

Moneycontrol News
first published: Apr 24, 2022 08:26 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
CloseOutskill Genai